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Abstract
Background The aim of this study was to assess the
accuracy of stress 99m technetium tetrofosmin
myocardial perfusion imaging for the diagnosis of in
stent stenosis (ISS).
Methods We studied 72 patients who underwent
exercise or dobutamine stress 99m technetium tetro-
fosmin imaging, 0.9–0.5 years after percutaneous
coronary interventions in which stents were de-
ployed. Coronary angiography was performed within
3 months of the stress test. ISS was defined as ‡50%
stenosis in a coronary segment with previous stent-
ing. Significant coronary artery disease (CAD) was
defined as ‡50% stenosis within or outside the stented
coronary segment.
Results The stent was deployed in 1 coronary artery
in 52 patients, and in 2 coronary arteries in 20 patients
(a total of 92 detected in 42 (58%) patients (51 stents).
Reversible perfusion abnormalities were present in 34
of patients with ISS (sensitivity=81%, CI 70–94).
Regional sensitivity for diagnosis of stenosis per stent
was 76% (CI 65–88), specificity was 83% (CI 71–94)
and accuracy was 79% (CI 69–85). Reversible per-
fusion abnormalities were detected in ‡2 vascular
distributions in 15 of 22 patients with multi-vessel
CAD and in 5 of 50 patients without (sensitivity for
identifying multivessel CAD=68%, CI 50–89; speci-
ficity=90%, CI 82–98; and accuracy=83%, CI 75–90).
Conclusion Stress 99m technetium tetrofosmin
myocardial perfusion imaging is a useful non-invasive
technique for the diagnosis of in stent stenosis and
extent of CAD in patients with previous percutanen-
ous coronary artery interventions.
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Introduction
Percutaneous coronary intervention (PCI) with stent
implantation is an increasingly used technique for
restoration of myocardial perfusion and treatment of
myocardial ischemia in patients with obstructive
coronary artery disease (CAD) [1–2]. The improved
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outcome with the use of stents, and the implement of
new antiplatelet agents have resulted in a significant
increase in the number of percutaneous revasculari-
zation procedures over the last decade. As a result,
the use of, and indications for, PCI have greatly ex-
panded [1–2]. Nevertheless, in stent stenosis (ISS)
remains a major clinical problem [3, 4].
The non-invasive evaluation of CAD after PCI is a
clinical challenge. Patients may remain asymptomatic
or have atypical symptoms despite restenosis or
progression of CAD in other coronary arterial seg-
ments. Coronary angiography is not recommended as
a routine follow up tool due to the associated risk and
the high cost. Exercise electrocardiography has a
limited accuracy for detection of restenosis and
localization of CAD, particularly due to the high
incidence of baseline electrocardiographic abnor-
malities in this population [4]. Stress radionuclide
myocardial perfusion imaging has been used for the
diagnosis of restenosis after PCI [4–11]. However,
published experience with the diagnostic accuracy of
this technique after coronary artery stenting is very
limited. The aim of this study was to assess the
accuracy of stress 99m technetium tetrofosmin
myocardial perfusion imaging for the diagnosis of




We studied 72 patients with previous PCI and suc-
cessful stent implantation who were referred for
evaluation of myocardial ischemia by stress 99m
technetium tetrofosmin single photon emission com-
puted tomography (SPECT). All patients underwent
quantitative coronary angiography within 3 month of
the stress test. The stress test was performed
1 months–3 years (mean=0.9–0.5 years) after stent-
ing. Patients gave an informed consent to undergo the
stress test. Revasularization was complete in 62
(86%) patients. The stress test was performed within
6 months after stenting in 28 (39%) patients. The
protocol of this study was approved by the Hospital
Ethics Committee. Diabetes mellitus was defined as a
fasting glucose level ‡140 mg/dl or the need for
insulin or oral hypoglycemic agents. Hypercholes-
terolemia was defined as a total cholesterol ‡200 mg/
dl, or treatment with lipid-lowering medications.
Hypertension was defined as repeated blood pressure
measurements >140/90 mm Hg or intake of antihy-
pertensive medications. Contraindications for the test
were severe heart failure, severe valvular heart dis-
ease, severe hypertension (blood pressure ‡180/
110 mm Hg), hypotension (blood pressure <90/
60 mm Hg) and unstable chest pain.
Mean age was 57–10 year. There were 55 men
(76%). Risk factors were hypertension in 23 (32%)
patients, diabetes in 12 (17%) patients, hypercholes-
terolemia in 41 (57%) and smoking in 19 (26%) pa-
tients. Thirty (42%) patients had a history of previous
myocardial infarction, and 7 (10%) patients had a
history of heart failure. Thirty six patients (50%) had
angina and 11 (15%) patients had atypical chest pain.
Medications included beta-blockers in 46 (64%),
angiotensin converting enzyme inhibitors in 24
(33%), and calcium channel blockers in 25 (35%)
patients.
Stress test protocols
Patients were instructed to discontinue beta blockers,
at least 24 h before the stress test, whenever appli-
cable. Other medications were not routinely discon-
tinued. The choice of stress test type was based on
ability to exercise. Exercise stress test was performed
in 37 patients using a symptom-limited upright
bicycle ergometry test with stepwise increment of
20 Watts every minute. Dobutamine-atropine stress
testing was performed in 35 patients. Dobutamine
was infused intravenously, starting at a dose of
10 lg/kg/min for 3 min, increasing by 10 lg/kg/
min every 3 min up to a maximum dose of 40 lg/kg/
min. If the test end-point was not reached at a do-
butamine dose of 40 lg/kg/min, atropine (up to
1 mg) was given intravenously. Blood pressure, heart
rate, and electrocardiography were continuously
monitored. Test end-points were achievement of
target heart rate (85% of maximum age predicted
heart rate), horizontal or downsloping ST-segment
depression >2 mm at an interval of 80 ms after the J-
point compared with baseline, severe angina, systolic
blood pressure fall >40 mm Hg, blood pressure >240/
120 mm Hg, and significant cardiac arrhythmia.
Metoprolol was available to reverse the side effects if
needed. Three electrocardiographic leads were con-
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tinuously monitored. Cuff blood pressure measure-
ments and twelve-lead electrocardiography were re-
corded at rest and every minute during stress and
recovery. ST-segment depression was defined as a
>1 mm horizontal or downsloping ST-segment
depression occurring at 80 ms after the J point [12].
99m Technetium tetrofosmin SPECT imaging
An intravenous dose of 370 MBq of 99m technetium
tetrofosmin (Myoview, Amersham, and Bucking-
hamshire, United Kingdom) was administered
approximately 1 min before the termination of the
dobutamine or exercise test. For resting studies,
370 MBq of tetrofosmin were injected at least 24 h
after the exercise study. Images were acquired with a
Gammasonics single-head Rota camera without
attenuation or scatter correction, by using a low-en-
ergy all-purpose collimator. Thirty-two projections
were obtained over a 180 arc, from left posterior
oblique to right anterior oblique, with an acquisition
time of 45 s per projection. From the three-dimen-
sional data, oblique (short-axis) and sagittal (vertical
long-axis) images obtained perpendicular and parallel
to the long axis, respectively, were reconstructed. For
each study six oblique (short axis) slices from the
apex to the base, three sagittal (vertical long axis)
slices were defined. Each of the 6 short axis slices
was divided into 8 equal segments. The septal part of
the 2 basal slices was excluded from analysis because
this region corresponds to the fibrous portion of the
interventricular septum and normally exhibits re-
duced uptake. Consequently, a total of 47 segments
were identified (3 long axis and 44 short axis). The
interpretation of the scan was semiquantitatively
performed by visual analysis. Stress and rest tomo-
graphic views were reviewed side by side by an
experienced observer who was unaware of the pa-
tients’ clinical or angiographic data. A reversible
perfusion defect was defined as a defect on stress
images that partially or completely resolved at rest
in ‡2 contiguous segments and slices in the 47-segment
model [12]. This was considered diagnostic of signifi-
cant CAD or ISS. A reverse perfusion pattern was not
considered diagnostic of significant stenosis [13]. A
fixed perfusion defect was defined as a perfusion
defect on stress images in 2 or more contiguous
segments and slices, which persists at rest in the
47-segment model. For data reporting, 6 major left
ventricular myocardial segments were identified:
anterior, septal anterior, septal posterior, inferior,
posterolateral and apical. The interobserver and in-
traobserver agreement on presence of reversible
perfusion abnormalities in our laboratory are 92%
and 94% respectively.
Quantitative angiography
Coronary angiography was performed within
3 months from the stress test. Referral to angiography
was at the discretion of the patient’s cardiologist.
Quantitative coronary angiography was performed on
the stent itself and the stent-related vessel and major
branch vessels. The most normal-appearing area
within the stented vessel was considered the reference
segment representing 0% stenosis. ISS was consid-
ered present for stenoses both within or adjacent to
the stent and for new lesions in the stented vascular
territory >5 mm from the stent [6]. Significant CAD
was defined as a diameter stenosis ‡50% in a major
epicardial coronary artery, including the stented
coronary segment. The anterior, apical, septal and
anteroseptal walls were assigned to the left anterior
descending coronary artery (LAD). The postero-
lateral wall was assigned to the left circumflex (LCX)
coronary artery and its marginal branches. The infe-
rior wall and basal septal segments were assigned to
the right coronary artery (RCA) [12].
Statistical analysis
Continuous variables were presented as mean and
standard deviation and were compared using Student’s
t test. Sensitivity, specificity and accuracy of myocar-
dial perfusion imaging were calculated using standard
definitions and were presented with 95% Confidence
Intervals (CI). Comparison of proportions was made by
v2-test. A p value <0.05 was considered significant.
Results
Stress test data
There was a significant increase of heart rate (71–17
vs 132–20 beats/min) and systolic blood pressure
(131–21 vs 159–34 mm Hg) from rest to peak stress
respectively. ST segment depression occurred in 20
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(28%) patients and angina occurred in 34 (47%) pa-
tients with stress. The mean achieved workload with
exercise was 135–35 watts. The mean maximal do-
butamine dose was 33–10 lg/kg/min. Atropine was
administered in 18 patients. The target heart rate was
achieved in 60 (84%) patients (82% with exercise and
86% with dobutamine).
Coronary angiography
The stent was deployed in 1 coronary artery in 52
patients, and 2 coronary arteries in 20 patients (a total
of 92 coronary arteries with stents). Significant CAD
was detected in 52 (72%) patients. Among them, 30
had single vessel, 15 had 2 vessel and 7 had 3 vessel
CAD. ISS was detected in 42 (58%) patients, and
involved 51 (55%) stents.
Diagnostic accuracy of tetrofosmin SPECT
Myocardial perfusion was normal in 13 (18%) pa-
tients. Myocardial perfusion abnormalities were fixed
in 12 (17%) patients, and reversible in 47 (65%)
patients. Among patients with reversible defects, 9
had completely reversible defects and 38 had resting
perfusion defects as well. ISS in ‡1 coronary artery
was detected in 42 (58%) patients. Reversible per-
fusion abnormalities were present in 34 of them
(sensitivity=81%, CI 70–94). Table 1 presents the
regional accuracy for SPECT for diagnosis of ISS
based on coronary artery location. The diagnostic
accuracy was not different in the 3 major coronary
arterial regions. Reversible perfusion abnormalities
were detected in 43 of 52 patients with significant
CAD and in 4 of 20 patients without (overall sensi-
tivity=83%, 95% CI 72–93, specificity=80%, CI 63–
98, and accuracy=82%, 95% CI 73–91). Reversible
perfusion abnormalities were detected in ‡2 vascular
distributions in 15 of 22 patients with multi-vessel
CAD and in 5 of 50 patients without (sensitivity for
identifying multivessel CAD by detecting perfusion
abnormalities in multivessel distribution=68%, CI
50–89; specificity=90%, CI 82–98; and accuracy=
83%, CI 75–90).
Discussion
In this study we demonstrated that stress 99m tech-
netium tetrofosmin myocardial perfusion imaging
was a useful method for diagnosis of ISS and eval-
uation of extent of CAD in 72 patients who were
studied at a mean of 0.9 years after PCI with coro-
nary artery stenting. Reversible perfusion abnormal-
ities were detected in 81% patients of patients with
ISS. The accuracy was maintained in the 3 coronary
arterial distributions. The majority of patients with
multivessel CAD were identified by observing
perfusion abnormalities in multivessel distribution
with an accuracy of 83%. Therefore, stress myocar-
dial perfusion imaging is useful in determining
patients with large myocardial regions at risk after
stenting and selecting patients for further invasive
procedure.
Previous studies
Studies that specifically addressed the diagnostic
accuracy of stress radionuclide imaging in patients
with previous coronary stenting are very scarce and
involved a small number of coronary arteries with
ISS. Milavetz et al. studied 33 patients who under-
went stress SPECT imaging and follow up coronary
angiography. There were 22 stents with ‡50% ste-
nosis [6]. Sensitivity, specificity, positive predictive
value, negative predictive value, and accuracy of
SPECT were 95%, 73%, 88%, 89%, and 88%
respectively. Kosa et al. studied 82 patients, who
underwent 93 rest or stress SPECT studies using 201
thallium and 99m sestamibi 210–129 days after
Table 1 Regional accuracy of stress 99m technetium tetrofosmin myocardial perfusion imaging for the diagnosis of in stent stenosis
Stented Coronary Artery Sensitivity Specificity Accuracy
LAD 15/19 (79%, 61–97) 14/17 (82%, 64–95) 29/36 (81%, 68–94)
RCA 13/17 (79%, 65–94) 10/12 (76%, 56–97) 23/29 (83%, 62–97)
LCX 11/15 (73%, 51–96) 10/12 (83%, 62–97) 21/27 (78%, 62–94)
All stents 39/51 (76%, 65–88) 34/41 (83%, 71–94) 73/92 (79%, 69–85)
Diagnostic parameters are presented as % with corresponding 95% confidence interval. LAD=left anterior descending, LCX=left
circumflex, RCA=right coronary artery
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revascularization [5]. Coronary angiography revealed
a stenosis of >50% diameter in the region of the stent
in 19 arteries. Fifteen vascular territories with reste-
nosed stents showed stress-induced perfusion abnor-
malities (sensitivity=79%), while 62/80 territories
without restenosis did not (specificity=78%). Giedd
et al. pooled data from 8 studies, in which stress
radionuclide tomography and coronary angiography
were performed within 2 to 48 months of PCI mostly
without stenting [4]. The overall sensitivity and
specificity of radionuclide imaging for detecting
myocardial ischemia were both 79% and were
roughly equivalent in all three vascular territories.
To our knowledge, this is the first study to assess
the accuracy of 99m technetium tetrofosmin imaging
in evaluation of ISS. The study assessed the accuracy
of myocardial perfusion imaging in detecting ISS in a
larger number of stents compared to previous studies
with different isotopes. It is to be noted that the ab-
sence of perfusion abnormalities in some patients
with >50% stenosis does not necessarily mean a
limitation of myocardial perfusion imaging. In con-
trast, it may suggest that a given stenosis may not be
of sufficient functional severity to induce abnormal-
ities of perfusion during stress. Studies from our
center [12] and by Zellweger et al. [14] have shown
an excellent outcome after a normal stress myocardial
perfusion imaging in patients with previous PCI,
suggesting that myocardial perfusion may remain a
significant predictor of outcome, regardless of the
degree of anatomical abnormality.
Limitations of the study
Coronary angiography was performed according to
the discretion of the treating physician and not per
study protocol. Therefore, verification bias related to
performing coronary angiography in patients with
abnormal test may have influenced the results. This
may in part explain the relatively high incidence of
ISS in this study. The population was heterogeneous
with a wide time range after PCI and included pa-
tients with and without symptoms. We used dobuta-
mine and not vasodilator stress in patients unable to
exercise. Preferring vasodilator stress to dobutamine
for myocardial perfusion imaging was based on ear-
lier studies demonstrating better flow heterogeneity
with dipyridamole than dobutamine [15]. These
studies utilized small dose of dobutamine without
addition of atropine and do not represent the state of
art protocol of the dobutamine stress. Recent studies
have shown that the flow heterogeneity obtained by
high dose dobutamine-atropine stress is equal to that
obtained by dipyridamole [16]. Bin et al. demon-
strated that in coronary arterial beds with a noncritical
stenosis, the increases in myocardial blood flow and
velocity and capillary derecruitment are similar for
both dobutamine and adenosine [17]. Therefore, there
is no literature supported evidence to suggest a
superiority of vasodilator over dobutamine stress [18].
Conclusion
Stress 99m technetium tetrofosmin myocardial per-
fusion imaging is a useful non-invasive technique for
the diagnosis of ISS and extent of CAD in patients
with previous PCI. Therefore, the technique can assist
the physician in selecting patients for invasive pro-
cedures.
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